Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01960348 |
|---|---|
| Brief Title: | APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis |
| First Submitted : | October 9, 2013 |
| First Submitted that Met QC Criteria : | October 9, 2013 |
| First Posted : | October 10, 2013 (Estimate) |
| Results First Submitted : | August 7, 2018 |
| Results First Submitted that Met QC Criteria : | August 7, 2018 |
| Results First Posted : | September 6, 2018 |
| Last Update Submitted that Met QC Criteria : | November 18, 2018 |
| Last Update Posted : | December 11, 2018 |